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Preconditioning of the distal tubular epithelium of the human
kidney precedes nephrocalcinosis.
Background. Preterm neonates and renal transplant patients
frequently develop nephrocalcinosis. Experimental studies re-
vealed that crystal retention in the distal nephron, a process
that may lead to nephrocalcinosis, is limited to proliferat-
ing/regenerating tubular cells expressing hyaluronan and os-
teopontin at their luminal surface. Fetal and transplant kidneys
contain proliferating and/or regenerating cells since nephrogen-
esis is not completed until 36 weeks of gestation, while ischemia
and nephrotoxic immunosuppressants may lead to injury and
repair in renal transplants. This prompted us to investigate the
expression of hyaluronan and osteopontin and to correlate this
to the appearance of tubular calcifications both in fetal/preterm
and transplanted kidneys.
Methods. Sections of fetal/preterm kidneys and protocol
biopsies of transplanted kidneys (12 and 24 weeks posttrans-
plantation from the same patients) were stained for osteopon-
tin, hyaluronan, and calcifications (von Kossa).
Results. Hyaluronan and osteopontin were expressed at the
luminal surface of the epithelial cells lining the distal tubules of
all fetal kidneys at birth and in all kidney graft protocol biopsies
12 and 24 weeks posttransplantation. In 7 out of 18 surviving (at
least 4 days) preterm neonates crystal retention developed. In
renal allografts a striking increase (from 2/10 to 6/10) in tubular
crystal retention between 12 and 24 weeks posttransplantation
was observed. In addition, crystals were selectively retained in
distal renal tubules containing cells with hyaluronan and osteo-
pontin at their luminal surface.
Conclusion. The results of this study show that luminal ex-
pression of hyaluronan and osteopontin preceded renal dis-
tal tubular retention of crystals in preterm neonates and renal
transplant patients. We propose that the presence of this crystal
binding phenotype may play a general role in renal calcification
processes.
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Nephrocalcinosis, recently defined [1] as increased
calcium content of the kidney, is observed in specific
patient populations, including renal transplant patients
and preterm neonates. Renal calcifications in preterm
neonates, detected by roentgenograms or ultrasonogra-
phy, were first described in 1982 [2]. Varying incidences
(17% to 64%) have been reported since then [3]. Nephro-
calcinosis in preterm neonates is the cause of later com-
plications such as urinary tract obstruction and infection
resulting in decreased renal function on the longer term
[4, 5]. Increases in urinary stone salts saturation because
of the calcium and vitaminD–rich diet, low urinary citrate
concentration, and long-term furosemide treatment are
all factors that have been previously considered to explain
the enhanced crystal formation in tubules of preterms
[3, 6, 7]. Recently, intratubular microcalcifications have
been described in 13% of transplanted kidneys 26 weeks
posttransplantation [8] and in 42% 1 year posttransplan-
tation [9]. Importantly, these intratubular calcifications
have been associated with poor long-term graft survival
[10]. As in other individuals, a protein-rich diet may re-
sult in high urinary calcium and oxalate concentrations
and hence intratubular crystallization [6, 11].
The exact mechanisms leading to nephrocalcinosis in
these two patient groups, however, are unclear. The lo-
calization of renal calcifications in preterm neonates is
unknown, while in transplanted kidneys nephrocalcinosis
clearly presents as intratubular microcalcifications [9, 10].
Recent investigation has shown involvement of hyaluro-
nan, osteopontin, CD44, nucleolin-related-protein, an-
nexin II, and Tamm-Horsfal-protein in the processes of
tubular crystal formation and/or retention [12–16]. An
important step in the development of nephrocalcinosis is
the retention/trapping of passing crystals to the luminal
surface of cells in the distal nephron. Our own studies,
both in vitro and in vivo, have demonstrated that calcium
crystals do not adhere to an intact epithelium but solely
to a proliferating/regenerating epithelium with dedif-
ferentiated cells expressing hyaluronan, osteopontin,
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and their receptor CD44 at the luminal surface [12, 16].
Luminal hyaluronan and osteopontin expression is ab-
sent/sparse in normal renal epithelium but extensively
up-regulated following renal damage and the subsequent
proliferation/regeneration [12, 17–22]. During nephroge-
nesis, hyaluronan may play a role during branching mor-
phogenesis [23] and osteopontin has been proposed to
be involved in tubulogenesis [24]. In proliferating renal
tubular cell cultures, hyaluronan is identified as a major
crystal-binding molecule since hyaluronidase treatment
diminished crystal adhesion [16, 25]. Although controver-
sial, osteopontin is also considered to be a crystal-binding
molecule, it is found associated with hyaluronan and their
mutual receptor CD44 on a crystal-binding epithelium,
and therefore may play a role in crystal retention [12, 16,
26, 27].
In an attempt to extend our experimental results show-
ing the important role of the epithelial phenotype in crys-
tal retention, in a human clinical setting, we investigated
two patient populations presenting with a high incidence
of nephrocalcinosis (i.e., preterm born infants and re-
nal transplant patients) [3, 9]. Kidneys of both popula-
tions contain proliferating/regenerating nephrons since
nephrogenesis is not completed until 36 weeks of ges-
tation and posttransplant kidneys are damaged and re-
generate because of ischemia, nephrotoxic drugs (e.g.,
cyclosporine) and chronic graft rejection.
METHODS
Patients
Renal tissue from 52 human fetuses with gestational
age 15 to 40 weeks was available (archive Antwerp
University Hospital, Professor Dr. Van Marck). These
preterm neonates died soon after birth (<1 day) and
expression of hyaluronan and osteopontin during
nephrogenesis could be studied, in the absence of any
influence from diet and fluid intake. Consequently, these
kidneys did not contain crystals. Therefore, tubular crys-
tal localization and colocalization with luminal osteopon-
tin and hyaluronan was studied in 18 preterm neonates
who lived for at least 4 days (Dr. R. De Krijger, De-
partment of Pathology, Erasmus Medical Center, Rotter-
dam, The Netherlands) and hence received a diet known
to promote urinary crystallization for at least 4 days.
Two kidney biopsies, 12 and 24 weeks posttransplanta-
tion, were available from 10 transplant-patients (Trans-
plant Center, Medical School Hannover, Hannover, Ger-
many). The protocol biopsy program at the Hannover
Medical School is part of the routine medical care fol-
lowing transplantation and had been approved by the lo-
cal ethical committee. Patients were informed well about
the program before transplantation. Written consent was
obtained and participation in the program was not a re-
quirement for transplantation. The use of archive mate-
rial for research is permitted by local ethical committees
on the understanding of anonymity.
Hyaluronan and osteopontin staining
For hyaluronan staining, sections were incubated
20 minutes with 0.1% bovine serum albumin (BSA),
4 hours with biotinylated hyaluronan-binding-protein
(Seikagaku, Tokyo, Japan) (1/10000), 1 hour with avidin-
biotinylated-peroxidase-complex (Vector Laboratories,
Burlingame, CA, USA) and finally with peroxidase sub-
strate [diaminobenzidine (DAB)]. Nuclei were methyl
green counterstained.
Osteopontin was stained with LF123, a polyclonal
rabbit-antihuman osteopontin antibody (provided by Dr.
Fisher, National Institutes of Health, Bethesda, MD,
USA). Sections were incubated 20 minutes with nor-
mal goat serum, overnight with LF123, and subsequently
30 minutes with biotinylated goat-antirabbit antibody
(Vector Laboratories). Avidin-biotinylated-peroxidase-
complex (Vector Laboratories) and peroxidase substrate
[DAB or aminoethyl carbazole (AEC)] were used for de-
tection. Nuclei were methyl green counterstained.
von Kossa staining
Calcium deposits were visualized by von Kossa stain-
ing. Sections were incubated 45 minutes in 5% silver ni-
trate, 3 minutes with 1% pyrogallic acid, and 1 minute
fixed in 5% sodium thiosulfate. Sections were hema-
toxylin and eosin counterstained.
Tubular crystals
Renal tissue from preterm neonates that lived at least 4
days and from von Kossa–positive transplant patients was
used. Three sequential sections, stained for von Kossa,
hyaluronan and osteopontin were used to evaluate the
expression pattern of hyaluronan and osteopontin in
tubules with von Kossa–positive deposits.
RESULTS
Hyaluronan and osteopontin
Developing kidneys. Hyaluronan expression was
present in the interstitium of fetal kidneys during the
whole period of nephrogenesis studied (week 15 to 40).
However, the amount of interstitial hyaluronon dimin-
ished along with the decrease in interstitial volume re-
sulting from tubular growth. Besides the interstitium,
hyaluronan was found at the luminal surface of the
tubules. This tubular localization was observed, both in
cortex and medulla, from week 15 to 40. During later
nephrogenesis (from around week 27), luminal hyaluro-
nan was especially evident in newly formed, immature
tubules of the medulla and outer layer of the cortex.



























Fig. 1. Hyaluronan and osteopontin staining on fetal (A to F) and
transplanted (G and H) kidneys. Fetal kidneys of 18 weeks show
widespread interstitial hyaluron staining in both cortex (A) and medulla
(C), while at 27 weeks this staining becomes much less extensive to-
gether with the cortical interstial volume (B). Luminal staining in the
tubules is present in cortex and medulla (A and C, arrows). At 28 weeks
hyaluronon is mainly present in the immature, developing tubules of
the outer cortex (D). Osteopontin staining is clearly present in many
tubules of both cortex (E) and medulla (F) of a 27-week-old fetus (ar-
rows). Both hyaluronon (G) and osteopontin (H) are expressed at the
luminal surface (arrows) of the tubules in a kidney 24 weeks after trans-
plantation (200×).
Tubular osteopontin expression was present during
nephrogenesis (week 15 to 40) both in cortex and
medulla. Between week 15 and 21, however, expression
was minimal and only intracellular. Luminal osteopon-
tin expression was clearly present from week 24 on and
persisted until week 40. Since it is not possible to allow
proximal and distal nephron identification in immature
kidneys, hyaluronan and osteopontin expression could
not be attributed to specific parts of the nephron (Fig. 1A
to F).
Transplanted kidneys. Twelve and 24 weeks posttrans-
plantation all biopsies showed the presence of hyaluro-
nan and osteopontin at the luminal surface of distal
























Fig. 2. Serial sections from preterm and transplanted kidneys stained
for von Kossa and hyaluronan or osteopontin. The von Kossa–positive
tubules are clearly positive for hyaluronan or osteopontin (320×, except
second row 640×).
Tubular crystals
Developing kidneys. Seven out of 18 von Kossa–
stained sections from preterm neonates that lived for
at least 4 days showed intratubular calcium-containing
inclusions in distal tubules. This was in contrast to sec-
tions from preterm neonates who lived less than 1 day
since none of those showed any von Kossa–positive stain-
ing (Fig. 2). By means of von Kossa, hyaluronan-stained
and osteopontin-stained serial sections, it was shown
that crystal containing tubules also expressed luminal
hyaluronan or osteopontin. Interstitial calcifications were
not present.
Transplanted kidneys. Analyzing biopsies, obtained in
the same patients (N = 10), 12 and 24 weeks posttrans-
plantation, luminal expression of hyaluronan and osteo-
pontin was observed to precede the retention of crystals
in the tubules (Figs. 2 and 3). Indeed, 12 weeks posttrans-
plantation there was extensive hyaluronan and osteopon-
tin staining at the luminal membrane of distal tubules
in all biopsies, whereas only two out of ten patients
showed tubular crystals (von Kossa–positive tubules). At
24 weeks after transplantation, however, in six biopsies
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Fig. 3. Twelve weeks posttransplantation hyaluronan and osteopontin
were extensively present at the luminal membrane of distal tubules in
all biopsies, whereas only two patients showed tubular crystals (von
Kossa–positive tubules). At 24 weeks after transplantation, however, in
six biopsies calcium crystals were found attached to distal tubular cells
expressing hyaluronan and osteopontin.
out of ten, calcium containing crystals were found at-
tached to distal tubular cells expressing hyaluronan and
osteopontin. As in preterm neonates, in the transplanted
kidneys interstitial calcifications were never observed, in
the transplanted kidneys.
DISCUSSION
The extensive expression of hyaluronan and osteopon-
tin during nephrogenesis is in agreement with the im-
portant role of these molecules described during kidney
development [23, 24], while in transplanted kidneys the
up-regulated expression probably occurs in response to
ischemic renal damage and cyclosporine toxicity [17, 21,
28–30].
It can be concluded from this study that nephrocalci-
nosis in preterm neonates, like in transplanted kidneys,
arises from intratubular calcifications. Furthermore, this
study corroborates our observation in ethylene glycol (in-
duces both crystalluria and tubular damage)–treated rats
that crystal retention is associated with tubular regenera-
tion and luminal expression of hyaluronan and osteopon-
tin [12]. From these rat experiments, however, it could not
be concluded whether the retained crystals themselves
induced epithelial damage/regeneration and luminal
expression of hyaluronan and osteopontin, or whether
crystals were retained because of an already existing
(ethylene glycol-metabolites induced [31–33]) tubular
damage/regeneration and hence hyaluronan and os-
teopontin up-regulation. The current study shows that
luminal hyaluronan and osteopontin expression in distal
tubules precedes crystal retention. Hyaluronan and os-
teopontin are expressed in all fetal kidneys in view of
their immaturity, which may result in nephrocalcinosis
after preterm birth because of subsequent crystalluria
resulting from diet and/or medication. In transplanted
patients, ischemia/reperfusion damage during transplan-
tations followed by the exposure to nephrotoxic drugs
and on the longer-term chronic allograft rejection may be
responsible for acute and sustained expression of
hyaluronan and osteopontin, respectively. Exposing
these kidneys to a protein-rich/crystalluria-inducing diet
can result in nephrocalcinosis. This is in agreement with
the recent study of Pinheiro et al [10] who associated
acute tubular necrosis after transplantation with a pre-
disposition to the deposition of tubular crystals.
CONCLUSION
Expression of crystal-binding molecules (hyaluronan
and osteopontin) at the luminal surface of the proliferat-
ing/regenerating distal tubular cells precedes crystal re-
tention to the distal nephron epithelium, the first step of
nephrocalcinosis.
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